Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia

Winton, EF; Kota, V

Winton, EF (reprint author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA.

FUTURE ONCOLOGY, 2017; 13 (5): 395

Abstract

Myelofibrosis (MF) is a chronic malignancy of the blood-forming system caused by hyperactivation of JAK2/STAT signaling pathway. Small-molecule inhibi......

Full Text Link